Crossmark

[Translated article] Real-World Experience of Secukinumab Dose Optimization in Moderate-to-Severe Psoriasis. Retrospective, Single-Center Series of 11-Patients

Crossref DOI link: https://doi.org/10.1016/j.ad.2024.10.002

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Aguado Vázquez, Á.

Melgosa Ramos, F.J.

Alonso Díez, C.

Mateu Puchades, A.
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2024-10-05
More Information

This article is maintained by: Elsevier

Article Title: [Translated article] Real-World Experience of Secukinumab Dose Optimization in Moderate-to-Severe Psoriasis. Retrospective, Single-Center Series of 11-Patients

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2024.10.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2023.08.021

Content Type: simple-article

Copyright: © 2024 AEDV. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below